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• The healthcare trends of Latin America appear to be changing alongside its rapid economic expansion; fewer clinical trials are being carried out in preventable, infectious diseases more commonly associated with poor healthcare availability and substandard living conditions, and there is an increasing focus on non-communicable diseases such as neoplasms, obesity and heart disease.
• Following the recent economic growth in Latin America, this analysis was undertaken to explore the corresponding shift in healthcare trends, by examining the number of clinical trials being conducted in the region and their changing focus on non-communicable and communicable diseases.
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• Between the five selected Latin American countries, 6,346 unique, relevant studies were identified.
• Over the entire time period from 2000 to 2014, 90.7% of studies were concerning non-communicable diseases such as cancer, cardiovascular disease and musculoskeletal disorders, whilst 9.3% focused on communicable diseases. • An analysis over time saw a trend of an increasing proportion of trials in non-communicable diseases and a fall in the proportion of studies in communicable diseases.
-In 2000, non-communicable diseases accounted for 77.8% of studies, compared with 22.2% in communicable diseases; however, by 2014 these percentages were 95.2% and 4.8%, respectively (Figure 1 ). • There were 589 unique studies in communicable disease; 31.4% of these were in HIV/AIDS, one of the most infectious diseases in the region, responsible for approximately 7.2 deaths per 100,000 people across the five selected countries.
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• This figure is considerably smaller than the mortality rates for the most deadly non-communicable diseases however; cardiovascular disease is responsible for 166.1 deaths per 100,000 people, and neoplasms and endocrine diseases are responsible for 90.7 and 44.5 deaths per 100,000 people, respectively.
• Figure 2 shows the number of studies carried out over time in HIV/AIDS and the three most commonly studied non-communicable disease areas: endocrine (14.2% of all studies), neoplasms (13.9%) and circulatory (11.9%).
-The number of studies in HIV/AIDS exhibits a gradual decline from a peak of 15.4% of all clinical studies conducted in 2001 to 1.2% in 2014. • It is of note that the number of patients enrolled in each study centre was considerably higher in the studies focusing on communicable disease compared with non-communicable.
-The mean study centre size for communicable disease studies was 2,006 persons and the median was 368 persons, whereas in studies on non-communicable disease the corresponding mean and median figures were 1,243 and 276, respectively.
Discussion
• Overall, there appears to be a trend towards increased numbers of studies in non-communicable diseases, compared with those in communicable disease.
• HIV/AIDS was the most commonly researched communicable disease, despite seeing a gradual fall in the total proportion of all studies since 2001.
-The number of studies conducted in different disease areas appeared to be associated with the mortality rates for the most serious conditions. • Of the five selected Latin American countries, Brazil has consistently contributed the most research, in terms of total clinical studies conducted.
• This research was limited to the data input on ClinicalTrials.gov and as such, any non-registered studies at the time of the search will not have been included in the analysis. • The sizeable difference in average number of participants in trials of communicable and non-communicable disease may be due to varying study designs. 
